» Articles » PMID: 33851288

Burnout and the Challenges Facing Pharmacists During COVID-19: Results of a National Survey

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2021 Apr 14
PMID 33851288
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background COVID-19 has impacted the psychological wellbeing of healthcare workers and has forced pharmacists to adapt their services. Objective To measure burnout and describe the work and psychosocial factors affecting pharmacists during COVID-19, and to compare males and females. Setting An online survey was distributed to a convenience sample of pharmacists practicing in any setting in Australia during April and June 2020. Method The survey collected demographic data, burnout scores using the validated Maslach Burnout Inventory (MBI), psychosocial and work-related variables using questions adapted from previous surveys. It was tested for readability by a group of pharmacists and academic clinicians before distribution via social media and professional organisations. Main outcome measure Burnout was calculated using mean MBI scores, descriptive statistics were used to report work and psychosocial variables and Pearson's chi-square compared males and females. Results Overall, 647 responses were analysed. Most participants were female n = 487 (75.7%) with hospital n = 269 (42.2%) and community n = 253 (39.9%) pharmacists well represented. Mean (SD) for emotional exhaustion (possible range 0-54) and depersonalisation (possible range 0-30) were 28.5 (13.39) and 7.98 (5.64), which were higher (increased burnout) than reported pre-COVID-19. Personal accomplishment (range 0-48, lower scores associated with burnout) mean (SD) 36.58 (7.56), was similar to previously reported. Males reported higher depersonalisation indicating more withdrawal and cynicism. Working overtime, medication supply and patient incivility were reported to affect work. Conclusion Pharmacists are experiencing burnout, with work and psychosocial factors affecting them during COVID-19. Knowledge of this and that males experience more depersonalisation is valuable to inform advocacy and interventions to support pharmacists.

Citing Articles

Changes in provision of extended community pharmacy services in Aotearoa New Zealand, 2018 to 2022.

Officer T, McDonald J, Jeffreys M, Cumming J, Russell L, McKinlay E BMC Health Serv Res. 2024; 24(1):1571.

PMID: 39696269 PMC: 11653777. DOI: 10.1186/s12913-024-11948-3.


Prevalence and Factors Associated with Burnout among Community Pharmacists in Saudi Arabia: Findings and Implications.

Alhomoud I, Alrasheedy A Healthcare (Basel). 2024; 12(18).

PMID: 39337175 PMC: 11430934. DOI: 10.3390/healthcare12181834.


Analyzing the Impact of COVID-19 on the Well-Being of Pharmacists: A Narrative Review.

Palnati S, Bhakta S, Patel P, Newell B Cureus. 2024; 16(8):e66804.

PMID: 39268304 PMC: 11392584. DOI: 10.7759/cureus.66804.


Evaluation of Mental Health and Well-Being Among Kansas Pharmacists Post-COVID-19 Pandemic.

Bhakta S, Palnati S, Patel P, Newell B Cureus. 2024; 16(8):e65962.

PMID: 39221323 PMC: 11365581. DOI: 10.7759/cureus.65962.


Occupational burnout and job satisfaction among community pharmacists.

Katsogiannis I, Manara E, Peletidi A, Bistaraki A, Constantinides T, Kontogiorgis C Explor Res Clin Soc Pharm. 2024; 14:100445.

PMID: 38726241 PMC: 11078698. DOI: 10.1016/j.rcsop.2024.100445.


References
1.
Hasan S, Kow C, Zaidi S . Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures?. Res Social Adm Pharm. 2020; 17(2):456-459. PMC: 7252013. DOI: 10.1016/j.sapharm.2020.04.033. View

2.
Higuchi Y, Inagaki M, Koyama T, Kitamura Y, Sendo T, Fujimori M . A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan. BMC Public Health. 2016; 16:534. PMC: 4939052. DOI: 10.1186/s12889-016-3208-5. View

3.
Wilder-Smith A, Chiew C, Lee V . Can we contain the COVID-19 outbreak with the same measures as for SARS?. Lancet Infect Dis. 2020; 20(5):e102-e107. PMC: 7102636. DOI: 10.1016/S1473-3099(20)30129-8. View

4.
Sasangohar F, Jones S, Masud F, Vahidy F, Kash B . Provider Burnout and Fatigue During the COVID-19 Pandemic: Lessons Learned From a High-Volume Intensive Care Unit. Anesth Analg. 2020; 131(1):106-111. PMC: 7173087. DOI: 10.1213/ANE.0000000000004866. View

5.
Elbeddini A, Wen C, Tayefehchamani Y, To A . Mental health issues impacting pharmacists during COVID-19. J Pharm Policy Pract. 2020; 13:46. PMC: 7374072. DOI: 10.1186/s40545-020-00252-0. View